CLINICAL_TRIALS
trial_result
· 2020-01-10
Clinical Trial Update: Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee [Phase 3]
Summary
Phase 3 long-term safety and efficacy study of tanezumab in osteoarthritis of the hip or knee completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Chronic Pain, Osteoarthritis, Hip | Phase 3 | Status: COMPLETED | Results posted: 2020-01-10